# clindamycin phosphate

NDC: 0338-9545
Generic name: clindamycin phosphate
Labeler / Manufacturer: Baxter Healthcare Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20170420

FDA application: NDA208083

## Active ingredients

- CLINDAMYCIN PHOSPHATE: 300 mg/50mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-9545"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-9545
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44fa506b-90ac-42de-831b-5f3f1a500fc0